Monoclonal antibodies against the RGM A protein for use in the treatment of retinal nerve fiber layer degeneration

Details for Australian Patent Application No. 2010329955 (hide)

Owner Abbott GmbH & Co. KG

Inventors Mueller, Bernhard K.

Agent Spruson & Ferguson

Pub. Number AU-A-2010329955

PCT Pub. Number WO2011/070045

Priority 61/267,446 08.12.09 US

Filing date 8 December 2010

Wipo publication date 16 June 2011

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/070045 Priority application(s): WO2011/070045

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010329961-Liquid suspension concentrate formulations containing saflufenacil

2010329950-Highly reactive, stabilized adhesive based on polyisocyanate